Stay updated on Pembrolizumab Plus Lenvatinib Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Plus Lenvatinib Clinical Trial page.

Latest updates to the Pembrolizumab Plus Lenvatinib Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA final publication citation for LEAP-005 colorectal cancer results was added to the Publications section (Clin Colorectal Cancer. 2026 Jun;25(2):225-238.e2). The previous online-ahead-of-print citation (Clin Colorectal Cancer. 2026 Jan 22:S1533-0028(26)00005-8) was removed/replaced with the finalized record.SummaryDifference0.1%

- Check19 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing the previous Revision: v3.6.0. This reflects an updated version of the study details page rather than a substantive change to its content.SummaryDifference0.0%

- Check33 days agoChange DetectedEnrollment status updated to show completion and no longer recruiting. New help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) plus a revision tag (v3.6.0) were added, and the Intervention/Treatment header formatting was standardized.SummaryDifference0.2%

- Check40 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, indicating a newer version of the page. This metadata update does not alter the study details or visible content.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing v3.5.3. This represents a routine page revision without changes to the study data or on-page sections describing the trial.SummaryDifference0.0%

- Check68 days agoChange DetectedAdds a new LEAP-005 publication entry detailing results for gastric, biliary tract, and pancreatic cancers to the Publications section. Removes several 2025 postings from Publications, updating the record with newer citations.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Plus Lenvatinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Lenvatinib Clinical Trial page.